A search for axion-like particles was performed at the 400 GeV proton beam-dump experiment at CERN. Exploring an empty decay region of 35 m length and 9 m2 cross section, we searched for decays of neutral and penetrating scalar particles into a pair of photons, electrons or muons. No evidence for the existence for such particles was found in this experiment. Limits are quoted as a function of the mass and of the model independent decay constant of axions
NA62 is a fixed-target experiment at the CERN SPS dedicated to measurements of rare kaon decays. Such measurements, like the branching fraction of the K+ → π+ ν ν̄ decay, have the potential to bring significant insights into new physics processes when comparison is made with precise theoretical predictions. For this purpose, innovative techniques have been developed, in particular, in the domain of low-mass tracking devices. Detector construction spanned several years from 2009 to 2014. The collaboration started detector commissioning in 2014 and will collect data until the end of 2018. The beam line and detector components are described together with their early performance obtained from 2014 and 2015 data.
A search for heavy neutrinos was conducted in the neutrino beam produced by the 400 GeV proton beam-dump and in the 400 GeV wide-band neutrino beam at CERN. A heavy neutrino associated with the τ lepton was searched for in the beam-dump experiment. No assumption on the nature of heavy neutrinos was made in the wide-band beam experiment. A search was made for neutrinos decaying into two electrons and a light neutrino. Since no events were observed, an upper limit on the neutrino mixing angles as a function of the neutrino mass is derived
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.